Status:
COMPLETED
Intra-parotid Facial Nerve Imaging in Parotidectomy
Lead Sponsor:
Samsung Medical Center
Conditions:
Parotid Tumors
Facial Nerve Paresis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
In this study, the investigators will evaluate the clinical usefulness of 3 dimensional double echo steady state MRI (3D-DESS MRI) for functional preservation of the facial nerve during parotidectomy....
Detailed Description
Surgical removal of tumors arising from the parotid gland (benign or malignant) is treatment of choice. However, the most detrimental complication of parotidectomy is facial weakness or facial nerve p...
Eligibility Criteria
Inclusion
- Parotid tumors subject to the surgery (parotidectomy)
- Parotid deep lobe tumors or tumor located in both superficial and deep parotid glands (Tumor medial to the facial nerve line, a line connecting the lateral border of mandible and the posterior belly of digastric muscle on CT scans or tumors crossing the facial nerve line on CT scans)
- Benign or malignant tumors
- Any size of parotid tumors
Exclusion
- Superficially located parotid tumor on CT or US (Tumor lateral to the facial nerve line, a line connecting the lateral border of mandible and the posterior belly of digastric muscle on CT scans)
- Previous parotid surgery in the affected parotid gland (Revision parotid surgery)
- Preoperative facial nerve palsy
- Cases with the facial nerve sacrifice during surgery for oncological purpose (malignancy)
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT03822728
Start Date
August 1 2017
End Date
July 31 2021
Last Update
November 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710